16,577 Shares in Doximity, Inc. (NASDAQ:DOCS) Purchased by Virtu Financial LLC

Virtu Financial LLC purchased a new stake in Doximity, Inc. (NASDAQ:DOCS) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 16,577 shares of the company’s stock, valued at approximately $885,000.

Other hedge funds have also recently bought and sold shares of the company. Natixis Advisors LLC grew its holdings in Doximity by 43.5% in the 3rd quarter. Natixis Advisors LLC now owns 31,815 shares of the company’s stock worth $1,386,000 after buying an additional 9,644 shares in the last quarter. Thrivent Financial for Lutherans raised its stake in Doximity by 5.0% during the 3rd quarter. Thrivent Financial for Lutherans now owns 30,991 shares of the company’s stock valued at $1,350,000 after purchasing an additional 1,474 shares during the period. Commerce Bank purchased a new stake in shares of Doximity in the third quarter valued at $314,000. Charles Schwab Investment Management Inc. boosted its position in shares of Doximity by 4.4% in the third quarter. Charles Schwab Investment Management Inc. now owns 753,001 shares of the company’s stock worth $32,808,000 after buying an additional 31,966 shares during the period. Finally, Cerity Partners LLC grew its holdings in shares of Doximity by 21.4% during the third quarter. Cerity Partners LLC now owns 49,876 shares of the company’s stock valued at $2,173,000 after buying an additional 8,781 shares in the last quarter. Institutional investors and hedge funds own 87.19% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have weighed in on the company. The Goldman Sachs Group lifted their target price on Doximity from $58.00 to $80.00 and gave the company a “neutral” rating in a research note on Monday, February 10th. KeyCorp dropped their price objective on shares of Doximity from $70.00 to $65.00 and set an “overweight” rating on the stock in a research note on Wednesday, January 8th. Canaccord Genuity Group lifted their target price on shares of Doximity from $60.00 to $71.00 and gave the company a “hold” rating in a research note on Friday, February 7th. Needham & Company LLC upped their price target on shares of Doximity from $65.00 to $82.00 and gave the stock a “buy” rating in a research note on Friday, February 7th. Finally, Raymond James reiterated an “outperform” rating and set a $83.00 price objective (up from $65.00) on shares of Doximity in a report on Friday, February 7th. Eleven investment analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat.com, Doximity has an average rating of “Moderate Buy” and an average target price of $64.22.

Doximity Price Performance

Doximity stock opened at $66.39 on Tuesday. Doximity, Inc. has a fifty-two week low of $22.96 and a fifty-two week high of $85.21. The firm has a fifty day moving average price of $64.76 and a two-hundred day moving average price of $53.85. The firm has a market cap of $12.39 billion, a price-to-earnings ratio of 66.39, a P/E/G ratio of 4.10 and a beta of 1.34.

Insider Transactions at Doximity

In other Doximity news, Director Timothy S. Cabral sold 20,000 shares of the firm’s stock in a transaction that occurred on Monday, February 3rd. The stock was sold at an average price of $57.62, for a total value of $1,152,400.00. Following the sale, the director now owns 6,360 shares of the company’s stock, valued at $366,463.20. This trade represents a 75.87 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. 37.40% of the stock is currently owned by corporate insiders.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.